tiprankstipranks
Trending News
More News >
Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO

Spero Therapeutics (SPRO) Revenue

Compare
519 Followers

Spero Therapeutics Revenue

Spero Therapeutics had a revenue of 9.36M in the quarter ending Dec 31, 2024, with -30.54%. This bring the company's revenue in the last twelve months to 33.05M, Increased -65.40%. In the fiscal year ending Dec 31, 2024, Spero Therapeutics had annual revenue of 27.40M with -71.68% growth.
Revenue (ttm)
33.05M
Revenue Growth
-71.68%
P/S Ratio
1.27
Revenue/Employee
$856,125
Employees
32
Market Cap
$34.66M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
27.40M-69.34M-71.68%
Dec 31, 2023
96.73M48.16M+99.13%
Dec 31, 2022
48.58M30.32M+166.10%
Dec 31, 2021
18.26M8.93M+95.67%
Dec 31, 2020
9.33M4.59M+96.75%
Dec 31, 2019
4.74M776.00K+19.57%
Dec 31, 2018
3.97M1.99M+100.40%
Dec 31, 2017
1.98M1.64M+490.75%
Dec 31, 2016
335.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis